We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
(-0.26%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6
years
Top 10 Avg Time Held Equity + Options
2.7
years
Top 20 Avg Time Held Equity + Options
3.7
years
Avg Time Held Equity only
4.6
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$39.4M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$26.6M |
| 3 |
CVB Financial
CVBF
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$16.9M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$15.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$25.2M |
| 2 |
iShares Investment Grade Systematic Bond ETF
IGEB
|
+$18.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$6.13M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.91M |
| 5 |
SS&C Technologies
SSNC
|
+$3.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.84% |
| 2 | Technology | 15.96% |
| 3 | Healthcare | 9.75% |
| 4 | Financials | 7.52% |
| 5 | Communication Services | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
Xencor
XNCR
$1.75B
| $670 | ﹤0.01% |
63
-73
| -54% | -$1.21K |
2021 Q2
15 quarters
|
|
3177
DELISTED
REV Group
REVG
| $664 | ﹤0.01% |
21
+9
| +75% | +$291 |
2024 Q4
1 quarter
|
|
3178
vTv Therapeutics
VTVT
$109M
| $658 | ﹤0.01% |
38
| – | – |
2020 Q2
19 quarters
|
|
3179
EyePoint Inc
EYPT
$261M
| $656 | ﹤0.01% |
+121
| New | +$847 |
2025 Q1
0 quarters
|
|
3180
Borr Drilling
BORR
$1.43B
| $655 | ﹤0.01% |
299
-3,396
| -92% | -$10.2K |
2022 Q4
9 quarters
|
|
3181
DELISTED
Catalyst Pharmaceutical
CPRX
| $655 | ﹤0.01% |
27
| – | – |
2022 Q3
10 quarters
|
|
3182
Dorian LPG
LPG
$2.3B
| $648 | ﹤0.01% |
29
-94
| -76% | -$2.18K |
2024 Q4
1 quarter
|
|
3183
DELISTED
Thermon Group Holdings
THR
| $641 | ﹤0.01% |
23
-2
| -8% | -$58 |
2022 Q3
10 quarters
|
|
3184
Sable Offshore Corp
SOC
$637M
| $634 | ﹤0.01% |
+25
| New | +$640 |
2025 Q1
0 quarters
|
|
3185
Gorman-Rupp
GRC
$1.92B
| $632 | ﹤0.01% |
18
| – | – |
2023 Q2
7 quarters
|
|
3186
Rush Street Interactive
RSI
$2.16B
| $632 | ﹤0.01% |
59
+31
| +111% | +$408 |
2024 Q3
2 quarters
|
|
3187
Insteel Industries
IIIN
$586M
| $631 | ﹤0.01% |
24
-65
| -73% | -$1.8K |
2023 Q2
7 quarters
|
|
3188
DELISTED
E2open Parent Holdings
ETWO
| $628 | ﹤0.01% |
314
+203
| +183% | +$504 |
2023 Q2
7 quarters
|
|
3189
Green Plains
GPRE
$1.01B
| $621 | ﹤0.01% |
+128
| New | +$917 |
2025 Q1
0 quarters
|
|
3190
International Money Express
IMXI
$328M
| $618 | ﹤0.01% |
49
-76
| -61% | -$1.3K |
2021 Q4
13 quarters
|
|
3191
Intrepid Potash
IPI
$432M
| $617 | ﹤0.01% |
+21
| New | +$554 |
2025 Q1
0 quarters
|
|
3192
CryoPort
CYRX
$860M
| $614 | ﹤0.01% |
+101
| New | +$699 |
2025 Q1
0 quarters
|
|
3193
Health Catalyst
HCAT
$137M
| $612 | ﹤0.01% |
135
-96
| -42% | -$508 |
2024 Q2
3 quarters
|
|
3194
Universal Electronics
UEIC
$67.5M
| $612 | ﹤0.01% |
100
| – | – |
2024 Q2
3 quarters
|
|
3195
MaxLinear
MXL
$6.63B
| $608 | ﹤0.01% |
56
+26
| +87% | +$435 |
2024 Q4
1 quarter
|
|
3196
Life Time Group Holdings
LTH
$9.23B
| $604 | ﹤0.01% |
20
+16
| +400% | +$470 |
2024 Q4
1 quarter
|
|
3197
Tutor Perini Cor
TPC
$4.13B
| $603 | ﹤0.01% |
26
-9
| -26% | -$222 |
2024 Q3
2 quarters
|
|
3198
Bristow Group
VTOL
$1.16B
| $600 | ﹤0.01% |
19
| – | – |
2021 Q4
13 quarters
|
|
3199
STAAR Surgical
STAA
$1.1B
| $599 | ﹤0.01% |
+34
| New | +$682 |
2025 Q1
0 quarters
|
|
3200
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
| $585 | ﹤0.01% |
10
| – | – |
2024 Q4
1 quarter
|
|
Similar funds
Parallel Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.
- Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
- Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
- Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
- Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
- Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
- Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.
Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.